Enzon presents pre-clinical data on controlled release of PEGylated interferon-beta-1b and PEGylated anti-TNF-a antibody fragment at the Controlled Release Society annual meeting
Market Watch, The Wall Street Journal, 16 Jul 2012
Accessed on 16 Jul 2012 from http://www.marketwatch.com/story/enzon-presents-pre-clinical-data-on-controlled-release-of-pegylated-interferon-beta-1b-and-pegylated-anti-tnf-a-antibody-fragment-at-the-controlled-release-society-annual-meeting-2012-07-16.